India's Sun Continues To Face Resistance For Complete Takeover Of Israel's Taro
This article was originally published in PharmAsia News
Executive Summary
India's Sun Pharmaceutical Industries has offered to buy the remaining 34% of shares in Israel's Taro Pharmaceutical Industries that Sun did not already own